ATP Clinical Research

Costa Mesa, California 94105

3 studies enrolling now · 20 studies all time

What they study most

Agitation Associated With Alzheimer's Dementia, Alzheimer Dementia, Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease Psychosis, Central Nervous System Diseases, Cognition, Early Alzheimer's Disease, Irregular Sleep Wake Rhythm Disorder, Late Onset Alzheimer Disease, Major Depressive Disorder, Neurodegenerative Diseases

Studies at this site

• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study — Enrolling by invitation
• Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease — Running, not enrolling
• Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects — Stopped early
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
• A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease — Completed
• SUBLOCADE Long-term Outcomes — Completed
• A Study of Paliperidone Palmitate 6-Month Formulation — Completed
• Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) — Completed
• Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients — Completed
• A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder — Completed
• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) — Completed
• A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder — Completed
• A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease — Withdrawn before enrolling
• Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease — Completed
• Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease — Completed